These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide? Aracil-Bolaños I; Sampedro F; Pujol J; Soriano-Mas C; Gónzalez-de-Echávarri JM; Kulisevsky J; Pagonabarraga J Hum Brain Mapp; 2021 Dec; 42(17):5736-5746. PubMed ID: 34510640 [TBL] [Abstract][Full Text] [Related]
26. Default-Mode Network Connectivity Changes During the Progression Toward Alzheimer's Dementia: A Longitudinal Functional Magnetic Resonance Imaging Study. Malotaux V; Dricot L; Quenon L; Lhommel R; Ivanoiu A; Hanseeuw B Brain Connect; 2023 Jun; 13(5):287-296. PubMed ID: 36103377 [No Abstract] [Full Text] [Related]
27. Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease. Xia Y; Dore V; Fripp J; Bourgeat P; Laws SM; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe C; Masters CL; Coulson EJ; Maruff P Neurology; 2024 Jul; 103(2):e209626. PubMed ID: 38885444 [TBL] [Abstract][Full Text] [Related]
28. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773 [TBL] [Abstract][Full Text] [Related]
29. Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease. Insel PS; Kumar A; Hansson O; Mattsson-Carlgren N; Neurology; 2023 Jul; 101(1):e20-e29. PubMed ID: 37085326 [TBL] [Abstract][Full Text] [Related]
30. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Sheline YI; Raichle ME; Snyder AZ; Morris JC; Head D; Wang S; Mintun MA Biol Psychiatry; 2010 Mar; 67(6):584-7. PubMed ID: 19833321 [TBL] [Abstract][Full Text] [Related]
31. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease. Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156 [TBL] [Abstract][Full Text] [Related]
32. Biomarker validation of a decline in semantic processing in preclinical Alzheimer's disease. Papp KV; Mormino EC; Amariglio RE; Munro C; Dagley A; Schultz AP; Johnson KA; Sperling RA; Rentz DM Neuropsychology; 2016 Jul; 30(5):624-30. PubMed ID: 26595826 [TBL] [Abstract][Full Text] [Related]